It is a common practice to conduct medical trials in order to compare a new therapy with a standard-ofcare based on paired data consisted of pre-and post-treatment measurements. In such cases, a great interest often lies in identifying treatment effects within each therapy group as well as detecting a between-group difference. In this article, we propose exact nonparametric tests for composite hypotheses related to treatment effects to provide efficient tools that compare study groups utilizing paired data.
carried out a study to examine the tolerability and efficacy of methylphenidate (MPH) and behavior modification therapy (BMOD), where multiple comparisons with the Bonferroni technique using the independent sample t-tests and the pairwise t-tests were conducted.
The former tests were implemented to evaluate between-group differences in baseline characteristics and measures of tolerability (the Pittsburgh Side Effect Rating Scale, say PSERS). The latter ones were undertaken in the SMD group to compare pre-and post-differences in CDRS-Rts and PSERS from lowdose MPH to high dose MPH. In this article, we avoid considerations of combined p-values, proposing a simple and efficient way to create nonparametric tests that attends to special alternative hypotheses directly, in an analogy to parametric likelihood ratio tests. Note that, in controlling the type I error, the used t-tests are known to be inefficient, when utilized data are skewed, and the applied Bonferroni method tends to be conservative. The nonparametric statistical analyses of two populations described above require to consider more versatile testing methods than those well addressed in the classic literature (e.g., [10, 11] ). In this article, we propose and examine distribution-free tests for multiple hypotheses to detect various differences related to treatment effects in study groups based on paired data.
To formalize the testing problems, let ( , ) be independent identically distributed (i.i.d.) pairs of observations within a subject j from sample i, where i 1, 2 are referred to as treatments; j are referred to as subjects. In the nonparametric setting, the classic one-sample tests for paired data, e.g. the paired t-test and the Wilcoxon signed rank test, are based on differences , where denotes a within-pair difference of subject j from sample i, i 1, 2; j . Note that and consist of i.i.d. observations from populations and with distribution functions, say, and , respectively. In contexts of treatment evaluations, can be defined to be the difference of measurements between pre-and post-treatment. In this article, we consider different hypotheses simultaneously for the symmetry of and/or (detecting a treatment effect into groups) as well as for the equivalence . Here we refer to the nonparametric literature to connect the term "treatment effect" with tests for symmetry (e.g., Wilcoxon [10] When parametric forms of the relevant distributions are known, corresponding parametric likelihood ratios can be easily applied to test for the problems mentioned above. According to the Neyman-Pearson lemma, the parametric likelihood ratio tests are optimal decision rules (e.g., Lehmann and Romano [11] ;
Vexler and Wu [12] ; Vexler et al., [13] ). We propose to approximate corresponding likelihood ratios using an empirical likelihood (EL) concept. The EL methodology has been addressed in the statistical literature as one of powerful nonparametric techniques (e.g., Lazar and Mykand [14] ; Owen [15] [16] [17] ; Qin and Lawless [18] ; Vexler et al., [19] [20] [21] ; Yu et al., [22] [23] ). The EL methodology allows researchers to use distribution-free procedures with efficient characteristics that are asymptotically close to those of related parametric likelihood approaches (e.g., Lazar and Mykand [14] ). The EL approach is developed via terms of cumulative distribution functions (e.g., Owen [17] ; Vexler et al., [24] ; Vexler and Yu [25] ).
Vexler and Yu [25] analyze the CDRS-Rts data is presented in Section 4. In Section 5, we provide some concluding remarks.
Statement of Problems and Methods

Hypotheses setting
To test for equality of the distribution of the new therapy group and the control therapy group based on paired observations and , one may consider the hypotheses, vs. .
In order to incorporate evaluation of the treatment effect on each therapy group, we point out three tests related to the null hypothesis, 1) the equality of the distributions of two therapy groups, and 2) no treatment effect in each group. This can be presented by , and 2)
, for all . Against , we can set up three different alternative hypotheses, namely 
Test statistics
In this section, we develop test statistics for Tests 1-3. The proposed three tests will be shown to be exact.
Test 1: vs.
Consider Medicine   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41 (9) is asymptotically consistent. The upper and lower bounds for the integer parameters m and k in definitions of (7) and (8) shown that the proposed nonparametric test has power comparable with that of correct parametric likelihood ratio tests. Thus, in contexts of the study described in Section 1, the direct application of the density-based EL ratio test (9) provides an efficient evaluation of treatment effects with ADHD and SMD in children.
Test 2: vs.
Our goal is to test for vs. , , .
In a similar manner to the development of the density-based EL approximation to the ratio mentioned in Section 2.2.1, the EL ratio related to test for vs. can be defined as where are defined in (2) . Consider the density-based EL approximation to the corresponding ratio
The empirical constraint for values of can be constructed based on the symmetric property of . By analogy with equations (1)- (6) Similarly to (7) and (8), the density-based EL estimator of the ratio can be presented as (14) Finally, taking into account (10) and (14), the proposed test statistic for Test 2 can be constructed as
In this case, the decision rule developed for Test 2 is to reject the null hypothesis if 
where is a test threshold.
Test 3: vs.
Consider the following hypotheses of interest vs. , . 
where is a test threshold. Proof. We outline the proof in Appendix A1 provided in Supplementary material (S1) § .
Consider the testing problem vs. . Proof. We omit the proof, since it is similar to the proof of Proposition 1.
Null distributions of the proposed test statistics
To obtain critical values of the proposed tests, we utilize the fact that the proposed test statistics are based , of the null distributions. We first generated data of and from the standard normal distribution § Supporting information may be found in the online version of this article. Table 2 ).
------ Table 2 ------Remark 1. The definitions (9), (15) and (17) [24, 25] and [27] .
Remark 2. The computer codes related to the outputs of this section are provided in Supplemental Section S2. These codes can be easily modified to obtain results of the next section or to perform the proposed tests based on real data.
Simulation Study
In this section, we examine the power properties of the proposed tests in various cases using Monte Carlo simulations. The proposed tests based on (9), (15) , and (17), with =0.1, are compared with the common test procedures: the maximum likelihood ratio (MLR) tests, assuming parametric conditions on distributions of observations (for details of the constructions and definitions of the MLR tests, see
Appendix A2 of the supplementary material, S1); combined classic nonparametric tests with a structure based on the Wilcoxon signed rank test or/and the Kolmogorov-Smirnov test. We fixed the significance level of the tests to be 0.05 in all considered cases.
Power comparison with the parametric method (the MLR tests)
In order to present the comparative power of the proposed tests versus the corresponding MLR tests, we performed the following Monte Carlo study. Critical values of the MLR test statistics were obtained based on 50,000 simulations under based on N(0,1)-distributed observations Z. To study the powers of the tests, 10,000 samples for each size ( , ) were generated from a variety of distributions. Tables 3-5 depict the Monte Carlo powers of the proposed tests and those of the corresponding MLR tests. Medicine   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 Table 4 
------Table 3------
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When observations are normally distributed, as anticipated, the MLR tests would be more powerful than the proposed nonparametric tests. The tables show the powers of the proposed tests are very close to those of the MLR tests, demonstrating that the density-based EL tests are comparable to the parametric method that utilizes the correct information regarding distributions of observations. ------ Table 6 ------
Power comparison with classic nonparametric methods
In this section, we compare the power of the proposed tests to the power of procedures based on the classic nonparametric tests. ------ Table 7 ------
------Table 8------------Table 9------
The Monte Carlo outputs shown in Tables 7-9 indicate that the new tests have higher powers against the combined nonparametric tests. In particular, for the cases of small sample sizes (e.g., (10, 10), (25, 25) ), the proposed tests are significantly superior to the classic tests. In several cases, the powers of the proposed tests have values that are 3-4 times larger than those of the combined nonparametric tests.
Data Analysis
In this section, we apply the proposed method to the study described in Section 1, which evaluates treatment effects of ADHD and SMD in children. Study subjects were randomized to receive either the experimental 11 week group therapy program ( ) or community psychosocial treatment ( ).
We defined the former as group 1 and the latter as group 2. For each child enrolled in the study, CDRSRts was taken at the baseline (week 0) and endpoint (week 11). Specifically, we computed the differences of CDRS-Rts: , for i 1, 2; j , where stands for the CDRS-Rts assessed at baseline before subject receives treatment and represents another CDRS-Rts at the endpoint after subject receives treatment . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59 As can be seen from Figure 1 , it appears that both therapy groups have a decline in the CDRS-Rts after baseline but the decrease in the CDRS-Rts seems to be more significant in the group 1.
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------ Figure 1------ In the context of the study's interests to test a claim that the distributions of the changes in CDRS-Rts are not equivalent with respect to the therapy groups or at least one therapy group has a treatment effect, we performed the proposed test 1. In this case, the observed value of the test statistic by (9), with =0.1, is 22.8217 and the corresponding p-value is 0.00002, indicating the null hypothesis of "no group differences and the lack of treatment effects in both groups" is rejected. The combined nonparametric test (the two "W-tests" and one "K-S test") also rejects the null hypothesis with the p-value 0.000005. Based on these results, there is strong evidence to reject the null hypothesis.
In addition, to demonstrate applicability of the proposed tests, we carried out Test 2 that might be appropriate to test an assertion that there is a treatment effect in one group and no such effect in the other besides a group difference. The observed value of the test statistic by (15) , with =0.1, is 11.9370 and the corresponding p-value is 4×10 -5 . The combined nonparametric test (the "W-test" and one "K-S test") with the Bonferroni method also supports the result to reject the null hypothesis with the p-value of 5×10 -7 .
These results show that the proposed procedures are in conjunction with the classic tests, demonstrating that our proposed tests can be utilized in the ADHD and SMD study.
In addition to the analysis above, we also conducted a bootstrap type study to evaluate the efficiency (power) of the considered tests based on small datasets randomly selected from the original data. To perform this study for Test 1, we executed the following procedure. We randomly selected samples with the sample sizes of (9, 6), (9, 7), (11, 9), (13, 10), (13, 11) , (15, 13) from the original dataset.
Then we calculated the corresponding test statistic by (9) , where =0.1. We repeated this strategy 10,000 times calculating the proportion of rejections at of the null hypothesis; that is, we computed the percentage of times when . The bootstrap type study for Test 2 was also carried out following the same procedures as described above. The results regarding the proportion of the rejections of the null hypothesis for each considered test are provided in Table 10 . ------ Table 10 ------ Table 10 demonstrates that the proposed procedures have larger proportion of the rejections in comparison with the combined nonparametric tests. In particular, when the sample sizes are relatively small (e.g., (9, 6), (9, 7)), the differences in the proportions of the rejections between two approaches are strongly recognizable. For example, we selected a sample of size 9 from the group 1 and a sample of size 6 from the group 2. This sub-dataset was tested for the hypotheses vs.
(Test 1). In contrast to the result that the nonparametric test based on the two "W-tests" and one "K-S test" for vs.
is not statistically significant (the Bonferroni adjusted p-values of these classic tests are 0.0617, 0.1050, and 0.9873, respectively), the proposed Test 1, with =0.1, is statistically significant (pvalue=0.0005). Figure 2 shows the empirical histograms of and from the sub-dataset. All these results indicate that the proposed methods for Tests 1 and 2 are more sensitive to detect the difference between the null hypothesis and the alternative hypotheses involved in Tests 1 and 2 compared to the corresponding combined nonparametric tests.
------Figure 2------5 Concluding Remarks
In this article, we proposed and examined the two-sample density-based EL ratio tests based on paired observations. While constructing the tests, we used approximations to the most powerful test statistics with respect to the stated problems, providing efficient nonparametric procedures. The proposed tests are shown to be exact and simple in performing. The extensive Monte-Carlo studies confirmed powerful properties of the proposed tests. We showed our tests outperform different tests with a structure based on the Wilcoxon signed rank test and/or the Kolmogorov-Smirnov test, and outperform the parametric likelihood ratio tests when the underlying distributions are misspecified. The data example illustrated that the proposed tests can be easily and efficiently used in practice.
APPENDIX A. Computing the empirical constraint (11) in the development of Test 2
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A1.2 Proposed test 2
Here, we will consider the case of . That is, we will show that as , , .
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A2.2 Maximum likelihood ratio test statistic for Test 2
Under the assumption that , where and , 1,2, are unknown, the hypotheses vs.
are equivalent to the following hypotheses:
vs.
Thus, the maximum likelihood ratio for Test 2 can be formulated by Substituting the associated MLEs of , , and into the above likelihood ratio, , yields the following maximum likelihood ratio test statistic for Test 2:
where , , and .
A2.3 Maximum likelihood ratio test statistic for the Test 3
Assume , where and , 1,2, are unknown. The hypotheses: vs. are equivalent to the following hypotheses:
Accordingly, the corresponding MLR test statistic is
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S2
: R Codes applied to the Monte Carlo Simulations.
################################### ############## Test 1 ############# ###################################
#The next codes present computations of the test-1-statistic (9) # number of the Monte Carlo iterations k<-50000 # sample sizes n1<-10 n2<-10 # delta value used in the definitions (7) and (8) # sorting of the generated paired data z2 sz<-sort(z) # sorting of the combined sample z # density-based test statistic (log of eq. (7)) based on Sample 1 (z1)
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